Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Female

• Status: Completed
• Trial end date: 2021-01-06
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to investigate the optimal Ce of remifentanil for preventing emergence cough following extubation during general anesthesia in female who are reversed with sugammadex or neostigmine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ajou University School of Medicine
• Treatments: Neostigmine

Criteria

Inclusion Criteria:

• Laparoscopic cholecystectomy under general anesthesia

Exclusion Criteria:

• BMI > 30 kg/m2, respiratory infection, uncontrolled hypertension